Why the study?
Does elevated sdLDL-C measured by a new automated assay predict incident coronary heart disease better than standard LDL-C or NMR-derived small LDL concentrations?
Does elevated sdLDL-C measured by a new automated assay predict incident coronary heart disease better than standard LDL-C or NMR-derived small LDL concentrations?
A new automated assay for sdLDL-C identifies increased risk for incident CHD in normoglycemic individuals that would remain undetected using standard lipid measures.
No takes yet. Share an insight, caveat, or question.
Suggests automated sdLDL-C testing may identify hidden coronary risk in normoglycemic patients.
Tsai et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: